IEFM
IONS icon

IQ EQ Fund Management’s Ionis Pharmaceuticals IONS Stock Holding History

IQ EQ Fund Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.08M Sell
14,389
-779
-5% -$61.5K 0.08% 206
2025
Q4 		$1.2M Sell
15,168
-116
-0.8% -$8.73K 0.08% 194
2025
Q3 		$1,000K Buy
15,284
+2,021
+15% +$98.7K 0.07% 206
2025
Q2 		$524K Buy
13,263
+5,204
+65% +$170K 0.05% 253
2025
Q1 		$243K Buy
+8,059
New +$264K 0.03% 272

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IQ EQ Fund Management's IONS Position: Q1 2026 in Review

IQ EQ Fund Management reduced its Ionis Pharmaceuticals (IONS) stake by 5.1% in Q1 2026, selling an estimated $61.5K and leaving 14,389 shares worth $1.08M. The position accounts for 0.08% of the portfolio, ranked #206.

IQ EQ Fund Management first reported a position in IONS in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.2M in Q4 2025. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • IQ EQ Fund Management held 14,389 shares of Ionis Pharmaceuticals worth $1.08M as of Q1 2026.
  • IQ EQ Fund Management sold 779 Ionis Pharmaceuticals shares in Q1 2026, an estimated $61.5K.
  • Ionis Pharmaceuticals made up 0.08% of IQ EQ Fund Management's portfolio in Q1 2026, its #206 holding.
  • IQ EQ Fund Management first reported a position in Ionis Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • IQ EQ Fund Management's Ionis Pharmaceuticals position peaked at $1.2M in Q4 2025.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on IQ EQ Fund Management's 13F filing for Q1 2026, filed 11 May 2026.